Argus analyst Kevin Heal raised the price target on MetLife (NYSE: MET) to $80.00 (from $77.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE